menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Lipid Lowering: The End or the Means to Better CV Results?

Program Information
Recommended
Lipid Lowering: The End or the Means to Better CV Results?
RestartResume
The answer almost assuredly is patient-specific, but the question of lipid-lowering as the end or the means in measuring cardiovascular risk highli...
  • Overview

    The answer almost assuredly is patient-specific, but the question of lipid-lowering as the end or the means in measuring cardiovascular risk highlights the ongoing discussion in medicine about targets: whether how we get there is more important than just getting there. Dr. Roger Blumenthal, professor of medicine in the division of cardiology at Johns Hopkins University School of Medicine, goes beyond a focus on lipid numbers in this discussion with host Dr. Larry Kaskel. As Dr. Blumenthal explains, cost-effectiveness is a critical consideration when examining target points in lipid therapy.

     

    Brought to you by:

    NLA logo

     

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 9/16/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.